Treatment paradigms for treatment-resistant schizophrenia
- PMID: 38879270
- DOI: 10.1016/S2215-0366(24)00173-1
Treatment paradigms for treatment-resistant schizophrenia
Conflict of interest statement
CL reports receiving research grants from Karuna, Merck, and Neurocrine, consultant honoraria from Karuna, and medical honoraria from MDedge and Hatherleigh. ALD declares no competing interests.
Comment on
-
Psychological and psychosocial interventions for treatment-resistant schizophrenia: a systematic review and network meta-analysis.Lancet Psychiatry. 2024 Jul;11(7):545-553. doi: 10.1016/S2215-0366(24)00136-6. Lancet Psychiatry. 2024. PMID: 38879276
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources